IL13 and infection: For example, delivery of antisense oligonucleotides targeting the IL-4Rα (173) or a cell penetrating peptide targeting the STAT6 transcription factor (activated by both IL-4 and IL-13) (162) to neonatal mice at the time of RSV infection reduces enhanced disease upon RSV re-infection of adults.